NCT03348748 - Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

July 12, 2021

Study Completion Date

October 8, 2025

Conditions

Stage I Non-Small Cell Lung Cancer AJCC v7Stage IA Non-Small Cell Lung Carcinoma AJCC v7Stage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

DRUG

Stereotactic Body Radiation Therapy

Undergo lowest-dose of SBRT

DRUG

Stereotactic Body Radiation Therapy

Undergo lowest- or higher-dose of SBRT

DRUG

Stereotactic Body Radiation Therapy

Undergo highest-dose of SBRT

PROCEDURE

Thoracic Surgical Procedure

Undergo thoracic surgery

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors

lead

Roswell Park Cancer Institute

OTHER